Cargando…

Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the ‘trials within cohorts’ study ProBCI

INTRODUCTION: A better understanding of the molecular profile of bladder tumours, the identification of novel therapeutic targets, and introduction of new drugs and has renewed research interest in the field of bladder cancer. We describe the design and setup of a Dutch Prospective Bladder Cancer In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richters, Anke, Meijer, Richard P, Mehra, Niven, Boormans, Joost L, van der Heijden, Antoine G, van der Heijden, Michiel S, Kiemeney, Lambertus A, Aben, Katja K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130738/ https://www.ncbi.nlm.nih.gov/pubmed/34006553 http://dx.doi.org/10.1136/bmjopen-2020-047256

Ejemplares similares

The global burden of urinary bladder cancer: an update
por: Richters, Anke, et al.
Publicado: (2019)

Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancer
por: Richters, Anke, et al.
Publicado: (2021)

Body mass index and waist circumference in relation to risk of recurrence and progression after non‐muscle invasive bladder cancer
por: van Zutphen, Moniek, et al.
Publicado: (2023)

Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study
por: Vermeulen, S H, et al.
Publicado: (2015)

The present and future burden of urinary bladder cancer in the world
por: Ploeg, Martine, et al.
Publicado: (2009)

The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition
por: van Dorp, Jeroen, et al.
Publicado: (2023)

Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections
por: van Puffelen, Jelmer H, et al.
Publicado: (2023)

Adherence to the WCRF/AICR Cancer Prevention Recommendations and Risk of Recurrence in Non-muscle Invasive Bladder Cancer
por: van Zutphen, Moniek, et al.
Publicado: (2022)

Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the Bladder
por: van Wilpe, Sandra, et al.
Publicado: (2020)

Prognostic Relevance of Urinary Bladder Cancer Susceptibility Loci
por: Grotenhuis, Anne J., et al.
Publicado: (2014)

Non‐metastatic muscle‐invasive bladder cancer: the role of age in receiving treatment with curative intent
por: van Hoogstraten, Lisa M.C., et al.
Publicado: (2022)

Smoking intensity and bladder cancer aggressiveness at diagnosis
por: Barbosa, André L. A., et al.
Publicado: (2018)

The accuracy of cystoscopy in predicting muscle invasion in newly diagnosed bladder cancer patients
por: van Straten, Christine G. J. I., et al.
Publicado: (2023)

The prognostic value of family history among patients with urinary bladder cancer
por: Egbers, Lieke, et al.
Publicado: (2015)

Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder Cancer
por: van Kessel, Kim E.M., et al.
Publicado: (2016)

Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer
por: van Hoogstraten, Lisa M. C., et al.
Publicado: (2023)

No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression
por: Evers, Jelle, et al.
Publicado: (2020)

Intratumoral T cell depletion following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer is associated with poor clinical outcome
por: van Wilpe, Sandra, et al.
Publicado: (2022)

Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial
por: van Doeveren, T., et al.
Publicado: (2018)

Independent Replication of Published Germline Polymorphisms Associated with Urinary Bladder Cancer Prognosis and Treatment Response
por: Grotenhuis, Anne J., et al.
Publicado: (2016)

Sex differences in treatment patterns for non-advanced muscle-invasive bladder cancer: a descriptive analysis of 3484 patients of the Netherlands Cancer Registry
por: Richters, Anke, et al.
Publicado: (2022)

Urine cell-based DNA methylation classifier for monitoring bladder cancer
por: van der Heijden, Antoine G., et al.
Publicado: (2018)

Personal hair dye use and the risk of bladder cancer: a case–control study from The Netherlands
por: Ros, Martine M., et al.
Publicado: (2012)

Limited Funds for Bladder Cancer Research and What Can We Do About It
por: Boormans, Joost L., et al.
Publicado: (2016)

Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer
por: Ripping, Theodora M., et al.
Publicado: (2021)

Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial
por: Stockem, C.F., et al.
Publicado: (2023)

The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis
por: van der Heijden, Antoine G., et al.
Publicado: (2007)

The UroLife study: protocol for a Dutch prospective cohort on lifestyle habits in relation to non-muscle-invasive bladder cancer prognosis and health-related quality of life
por: de Goeij, Liesbeth, et al.
Publicado: (2019)

The influence of multidisciplinary team meetings on treatment decisions in advanced bladder cancer
por: Walraven, Janneke E.W., et al.
Publicado: (2022)

Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis
por: de Jong, Joep J., et al.
Publicado: (2019)

Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer
por: van der Horst, Geertje, et al.
Publicado: (2020)

Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
por: van der Vos, K. E., et al.
Publicado: (2020)

Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer
por: Pagliarulo, Fabio, et al.
Publicado: (2022)

Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder
por: van den Tempel, Nathalie, et al.
Publicado: (2018)

Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial
por: van Straten, Christine G.J.I., et al.
Publicado: (2023)

Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients
por: de Jong, Joep J., et al.
Publicado: (2018)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

LINC00857 expression predicts and mediates the response to platinum‐based chemotherapy in muscle‐invasive bladder cancer
por: Dudek, Aleksandra M., et al.
Publicado: (2018)

Long-Term Experience with Radiofrequency-Induced Hyperthermia Combined with Intravesical Chemotherapy for Non-Muscle Invasive Bladder Cancer
por: Brummelhuis, Iris S. G., et al.
Publicado: (2021)

Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
por: Beije, N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4rq80ub2mkj74p0ijq10p99d8g